Literature DB >> 12082567

Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia.

R J Anney1, M I Rees, E Bryan, G Spurlock, N Williams, N Norton, H Williams, A Cardno, S Zammit, S Jones, G Jones, B Hoogendoorn, K Smith, M L Hamshere, S Coleman, C Guy, M C O'Donovan, M J Owen, P R Buckland.   

Abstract

The dopamine D(3) receptor gene (DRD3) is a candidate for a number of psychiatric conditions including schizophrenia, bipolar disorder and alcohol and drug abuse. Previous studies have reported associations between polymorphisms in DRD3 and these disorders, but these findings may have reflected linkage disequilibrium with pathogenic variants that are further upstream. We have isolated and sequenced approximately 9 kb of genomic sequence upstream of the human DRD3 translational start site. Using 5' RACE, we have identified within this region three additional exons and two putative promoter regions which show promoter activity in three different cell lines. A 5' UTR identified only in lymphoblasts is spread over three exons and is 353 bp long. A second 5' UTR, found in adult and fetal brain, lymphocytes, kidney and placenta is spread over two exons and is 516 bp long. A 260-bp sequence within this 9 kb corresponds to a previously reported EST, but corresponding mRNA could not be found in the tissues above. The EST, 5' UTRs and putative promoter regions have been analysed for polymorphisms, revealing 10 single nucleotide polymorphisms, seven of which were tested for association in a large sample of unrelated patients with schizophrenia and matched controls. No associations were observed with schizophrenia. In addition we failed to replicate previous findings of association with homozygosity of the Ser9Gly variant. The results from this study imply that neither the coding nor the regulatory region of DRD3 plays a major role in predisposition to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082567     DOI: 10.1038/sj.mp.4001003

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  7 in total

Review 1.  Linkage and association studies of schizophrenia.

Authors:  Peter McGuffin; Kopal Tandon; Alejandro Corsico
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 2.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

3.  Genetic factors for alcohol dependence and schizophrenia: common and rare variants.

Authors:  Kesheng Wang; Xingguang Luo; Lingjun Zuo
Journal:  Austin J Drug Abuse Addict       Date:  2014-05-05

4.  Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders.

Authors:  Mesut Yıldız; Mehmet Vural; Mehmet Emin Erdal; Özlem İzci Ay; Şenay Görücü Yılmaz; İbrahim Fatih Karababa; Salih Selek
Journal:  Iran J Reprod Med       Date:  2015-04

5.  Revealing the alternative promoter usage of SAF/MAZ gene by bichromatic fluorescent reporter construct.

Authors:  Jianbo Ren; Dawei Guo; Xiaoyi Wang; Chao Zhang; Bo Wang; Zhe Gao
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

6.  Prediction of disease-related mutations affecting protein localization.

Authors:  Kirsti Laurila; Mauno Vihinen
Journal:  BMC Genomics       Date:  2009-03-23       Impact factor: 3.969

7.  No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis.

Authors:  Xing-Ling Qi; Jin-Feng Xuan; Jia-Xin Xing; Bao-Jie Wang; Jun Yao
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-23       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.